drugset / Trial / NCT00670384
Phase 2 Study in Adults Sensitized to Short Ragweed
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to identify an effective dose of allergen-specific immunotherapy for short ragweed (Ambrosia artemisiifolia) administered by an oral/sublingual route.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Business): “No funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Standardized Allergenic Extract, Short Ragweed (Ambrosia artemisiifolia) | Other / unclassified | — | Other |